Form 8-K - Current report:
SEC Accession No. 0000950170-25-082005
Filing Date
2025-06-05
Accepted
2025-06-05 08:30:09
Documents
14
Period of Report
2025-06-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20250605.htm   iXBRL 8-K 61223
2 EX-99.1 hcwb-ex99_1.htm EX-99.1 19625
3 EX-99.2 hcwb-ex99_2.htm EX-99.2 13196
4 GRAPHIC img90053791_0.jpg GRAPHIC 137410
5 GRAPHIC img90977312_0.jpg GRAPHIC 137410
  Complete submission text file 0000950170-25-082005.txt   591964

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20250605.xsd EX-101.SCH 24849
16 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20250605_htm.xml XML 4700
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 251025086
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)